Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128082) titled 'The Long COVID Treatment Trial' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Scripps Translational Science Institute
Condition:
Long COVID
Intervention:
Drug: Tirzepatide
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 2025
Target Sample Size: 1000
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128082
Published by HT Digital Content Services with permission from Health Daily ...